{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:14:50Z","timestamp":1783952090055,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent evidence suggests that dysregulated eIF3d expression may be critical in various genetic disorders as well as cancer. In this study, we observed that EIF3d levels increased in gallbladder cancer (GBC) samples compared with non-tumor tissue. High eIF3d levels were associated with advanced tumor stage and metastasis and were correlated with poor prognosis in 92 patients with GBC. Depletion of EIF3d in GBC cell lines inhibited cell proliferation, colony formation and metastasis and induced apoptosis and cell cycle arrest <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. In contrast, ectopic expression of eIF3d had the opposite effects. Moreover, in this study, we revealed that a novel non-translational factor function of eIF3d mediated its protumoral effects. In details, eIF3d stabilizes GRK2 protein by blocking ubiquitin-mediated degradation, consequently activates PI3K\/Akt signaling, and promotes GBC cell proliferation and migration. In conclusion, eIF3d promotes GBC progression mainly via eIF3d\u2013GRK2\u2013AKT axis and it may be used as a prognostic factor. The therapeutic targeting of eIF3d\u2013GRK2 axis may be a potential treatment approach for GBC.<\/jats:p>","DOI":"10.1038\/cddis.2017.263","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T12:42:52Z","timestamp":1496925772000},"page":"e2868-e2868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway"],"prefix":"10.1038","volume":"8","author":[{"given":"Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"BFcddis2017263_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A . Cancer statistics. CA Cancer J Clin 2015; 65: 5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFcddis2017263_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2014.08.036","volume":"355","author":"M Li","year":"2014","unstructured":"Li M, Lu J, Zhang F, Li H, Zhang B, Wu X et al. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL\/MAPK pathway. Cancer Lett 2014; 355: 201\u2013209.","journal-title":"Cancer Lett"},{"key":"BFcddis2017263_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-014-0276-y","volume":"14","author":"YJ Shu","year":"2015","unstructured":"Shu YJ, Weng H, Ye YY, Hu YP, Bao RF, Cao Y et al. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K\/AKT pathway. Mol Cancer 2015; 14: 12.","journal-title":"Mol Cancer"},{"key":"BFcddis2017263_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet 2014; 46: 872\u2013876.","journal-title":"Nat Genet"},{"key":"BFcddis2017263_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc2824","volume":"10","author":"D Silvera","year":"2010","unstructured":"Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254\u2013266.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2017263_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(01)01825-4","volume":"26","author":"KS Browning","year":"2001","unstructured":"Browning KS, Gallie DR, Hershey JW, Hinnebusch AG, Maitra U, Merrick WC et al. Unified nomenclature for the subunits of eukaryotic initiation factor 3. Trends Biochem Sci 2001; 26: 284.","journal-title":"Trends Biochem Sci"},{"key":"BFcddis2017263_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature14267","volume":"522","author":"AS Lee","year":"2015","unstructured":"Lee AS, Kranzusch PJ, Cate JH . eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature 2015; 522: 111\u2013114.","journal-title":"Nature"},{"key":"BFcddis2017263_CR8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1054\/bjoc.2001.1828","volume":"84","author":"R Pincheira","year":"2001","unstructured":"Pincheira R, Chen Q, Zhang JT . Identification of a 170-kDa protein over-expressed in lung cancers. Br J Cancer 2001; 84: 1520\u20131527.","journal-title":"Br J Cancer"},{"key":"BFcddis2017263_CR9","first-page":"988","volume":"57","author":"F Bachmann","year":"1997","unstructured":"Bachmann F, Banziger R, Burger MM . Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res 1997; 57: 988\u2013994.","journal-title":"Cancer Res"},{"key":"BFcddis2017263_CR10","first-page":"1047","volume":"30","author":"J Haybaeck","year":"2010","unstructured":"Haybaeck J, O'Connor T, Spilka R, Spizzo G, Ensinger C, Mikuz G et al. Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer. Anticancer Res 2010; 30: 1047\u20131055.","journal-title":"Anticancer Res"},{"key":"BFcddis2017263_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijc.20443","volume":"112","author":"G Chen","year":"2004","unstructured":"Chen G, Burger MM . p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation. Int J Cancer 2004; 112: 393\u2013398.","journal-title":"Int J Cancer"},{"key":"BFcddis2017263_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1","volume":"83","author":"A Dellas","year":"1998","unstructured":"Dellas A, Torhorst J, Bachmann F, Banziger R, Schultheiss E, Burger MM . Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 1998; 83: 1376\u20131383.","journal-title":"Cancer"},{"key":"BFcddis2017263_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1477-7819-10-119","volume":"10","author":"Z Wang","year":"2012","unstructured":"Wang Z, Chen J, Sun J, Cui Z, Wu H . RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells. World J Surg Oncol 2012; 10: 119.","journal-title":"World J Surg Oncol"},{"key":"BFcddis2017263_CR14","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-12-3084","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang H, Ru Y, Sanchez-Carbayo M, Wang X, Kieft JS, Theodorescu D . Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization. Clin Cancer Res 2013; 19: 2850\u20132860.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2017263_CR15","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1038\/onc.2010.152","volume":"29","author":"M Grzmil","year":"2010","unstructured":"Grzmil M, Rzymski T, Milani M, Harris AL, Capper RG, Saunders NJ et al. An oncogenic role of eIF3e\/INT6 in human breast cancer. Oncogene 2010; 29: 4080\u20134089.","journal-title":"Oncogene"},{"key":"BFcddis2017263_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/JTO.0b013e31819a5767","volume":"4","author":"F Cappuzzo","year":"2009","unstructured":"Cappuzzo F, Varella-Garcia M, Rossi E, Gajapathy S, Valente M, Drabkin H et al. MYC and EIF3H coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thoracic Oncol 2009; 4: 472\u2013478.","journal-title":"J Thoracic Oncol"},{"key":"BFcddis2017263_CR17","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/S0002-9440(10)63060-X","volume":"159","author":"O Saramaki","year":"2001","unstructured":"Saramaki O, Willi N, Bratt O, Gasser TC, Koivisto P, Nupponen NN et al. Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am J Pathol 2001; 159: 2089\u20132094.","journal-title":"Am J Pathol"},{"key":"BFcddis2017263_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ygeno.2010.02.002","volume":"95","author":"H Sudo","year":"2010","unstructured":"Sudo H, Tsuji AB, Sugyo A, Kohda M, Sogawa C, Yoshida C et al. Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. Genomics 2010; 95: 210\u2013216.","journal-title":"Genomics"},{"key":"BFcddis2017263_CR19","doi-asserted-by":"publisher","first-page":"e85823","DOI":"10.1371\/journal.pone.0085823","volume":"9","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yang Y, Zeng S, Tan Y, Lu G, Lin G . Identification of proteins related to epigenetic regulation in the malignant transformation of aberrant karyotypic human embryonic stem cells by quantitative proteomics. PLoS ONE 2014; 9: e85823.","journal-title":"PLoS ONE"},{"key":"BFcddis2017263_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature18954","volume":"536","author":"AS Lee","year":"2016","unstructured":"Lee AS, Kranzusch PJ, Doudna JA, Cate JH . eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation. Nature 2016; 536: 96\u201399.","journal-title":"Nature"},{"key":"BFcddis2017263_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/bab.1305","volume":"62","author":"H Li","year":"2015","unstructured":"Li H, Zhou F, Wang H, Lin D, Chen G, Zuo X et al. Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2\/M phase arrest. Biotechnol Appl Biochem 2015; 62: 615\u2013620.","journal-title":"Biotechnol Appl Biochem"},{"key":"BFcddis2017263_CR22","first-page":"10420","volume":"8","author":"Y Fan","year":"2015","unstructured":"Fan Y, Guo Y . Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt\/beta-catenin signaling pathway. Int J Clin Exp Pathol 2015; 8: 10420\u201310427.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFcddis2017263_CR23","first-page":"3969","volume":"9","author":"F Zhang","year":"2015","unstructured":"Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X et al. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Design Dev Ther 2015; 9: 3969\u20133987.","journal-title":"Drug Design Dev Ther"},{"key":"BFcddis2017263_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1476-5381.2010.00727.x","volume":"160","author":"P Penela","year":"2010","unstructured":"Penela P, Murga C, Ribas C, Lafarga V, Mayor F Jr . The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 2010; 160: 821\u2013832.","journal-title":"Br J Pharmacol"},{"key":"BFcddis2017263_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1189\/jlb.0403136","volume":"75","author":"A Vroon","year":"2004","unstructured":"Vroon A, Heijnen CJ, Lombardi MS, Cobelens PM, Mayor F Jr, Caron MG et al. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukocyte Biol 2004; 75: 901\u2013909.","journal-title":"J Leukocyte Biol"},{"key":"BFcddis2017263_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ebiom.2016.09.030","volume":"13","author":"L Nogues","year":"2016","unstructured":"Nogues L, Reglero C, Rivas V, Salcedo A, Lafarga V, Neves M et al. G protein-coupled receptor kinase 2 (GRK2) promotes breast tumorigenesis through a HDAC6-Pin1 axis. EBioMedicine 2016; 13: 132\u2013145.","journal-title":"EBioMedicine"},{"key":"BFcddis2017263_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13046-016-0370-7","volume":"35","author":"S Zhao","year":"2016","unstructured":"Zhao S, Cao Y, Liu SB, Wang XA, Bao RF, Shu YJ et al. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR. J Exp Clin Cancer Res 2016; 35: 97.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFcddis2017263_CR28","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA . A perspective on cancer cell metastasis. Science 2011; 331: 1559\u20131564.","journal-title":"Science"},{"key":"BFcddis2017263_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hep.26369","volume":"58","author":"H Xia","year":"2013","unstructured":"Xia H, Ooi LL, Hui KM . MicroRNA-216a\/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology 2013; 58: 629\u2013641.","journal-title":"Hepatology"},{"key":"BFcddis2017263_CR30","doi-asserted-by":"publisher","first-page":"e2201","DOI":"10.1038\/cddis.2015.324","volume":"7","author":"PF Zhang","year":"2016","unstructured":"Zhang PF, Li KS, Shen YH, Gao PT, Dong ZR, Cai JB et al. Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling. Cell Death Dis 2016; 7: e2201.","journal-title":"Cell Death Dis"},{"key":"BFcddis2017263_CR31","doi-asserted-by":"publisher","first-page":"e2503","DOI":"10.1038\/cddis.2016.373","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Liang Z, Xu X, Li J, Zhu Y, Meng S et al. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3\/AKT2\/c-myc and DNMT1 in bladder cancer. Cell Death Dis 2016; 7: e2503.","journal-title":"Cell Death Dis"},{"issue":"Pt 2","key":"BFcddis2017263_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel M, Serrels A, Frame MC, Brunton VG . E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 2013; 126 (Pt 2): 393\u2013401.","journal-title":"J Cell Sci"},{"key":"BFcddis2017263_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00441-014-1851-7","volume":"355","author":"G Breier","year":"2014","unstructured":"Breier G, Grosser M, Rezaei M . Endothelial cadherins in cancer. Cell Tissue Res 2014; 355: 523\u2013527.","journal-title":"Cell Tissue Res"},{"key":"BFcddis2017263_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrd3320","volume":"10","author":"R Lappano","year":"2011","unstructured":"Lappano R, Maggiolini M . G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011; 10: 47\u201360.","journal-title":"Nat Rev Drug Discov"},{"key":"BFcddis2017263_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc2069","volume":"7","author":"RT Dorsam","year":"2007","unstructured":"Dorsam RT, Gutkind JS . G-protein-coupled receptors and cancer. Nat Rev Cancer 2007; 7: 79\u201394.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2017263_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nrc1473","volume":"4","author":"RJ Epstein","year":"2004","unstructured":"Epstein RJ . The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies. Nat Rev Cancer 2004; 4: 901\u2013909.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2017263_CR37","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1158\/0008-5472.CAN-13-2708","volume":"74","author":"PK Chakraborty","year":"2014","unstructured":"Chakraborty PK, Zhang Y, Coomes AS, Kim WJ, Stupay R, Lynch LD et al. G protein-coupled receptor kinase GRK5 phosphorylates moesin and regulates metastasis in prostate cancer. Cancer Res 2014; 74: 3489\u20133500.","journal-title":"Cancer Res"},{"key":"BFcddis2017263_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.humpath.2016.06.012","volume":"56","author":"L Zhou","year":"2016","unstructured":"Zhou L, Wang MY, Liang ZY, Zhou WX, You L, Pan BJ et al. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance. Hum Pathol 2016; 56: 171\u2013177.","journal-title":"Hum Pathol"},{"key":"BFcddis2017263_CR39","doi-asserted-by":"publisher","first-page":"e0152856","DOI":"10.1371\/journal.pone.0152856","volume":"11","author":"MJ Billard","year":"2016","unstructured":"Billard MJ, Fitzhugh DJ, Parker JS, Brozowski JM, McGinnis MW, Timoshchenko RG et al. G protein coupled receptor kinase 3 regulates breast cancer migration, invasion, and metastasis. PLoS ONE 2016; 11: e0152856.","journal-title":"PLoS ONE"},{"key":"BFcddis2017263_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1677\/JOE-07-0562","volume":"198","author":"T Metaye","year":"2008","unstructured":"Metaye T, Levillain P, Kraimps JL, Perdrisot R . Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. J Endocrinol 2008; 198: 101\u2013110.","journal-title":"J Endocrinol"},{"key":"BFcddis2017263_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.bjc.6603490","volume":"96","author":"I Prowatke","year":"2007","unstructured":"Prowatke I, Devens F, Benner A, Grone EF, Mertens D, Grone HJ et al. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. Br J Cancer 2007; 96: 82\u201388.","journal-title":"Br J Cancer"},{"key":"BFcddis2017263_CR42","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1073\/pnas.0905778107","volume":"107","author":"P Penela","year":"2010","unstructured":"Penela P, Rivas V, Salcedo A, Mayor F Jr . G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc Natl Acad Sci USA 2010; 107: 1118\u20131123.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017263_CR43","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1038\/sj.emboj.7600794","volume":"24","author":"J Ho","year":"2005","unstructured":"Ho J, Cocolakis E, Dumas VM, Posner BI, Laporte SA, Lebrun JJ . The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. EMBO J 2005; 24: 3247\u20133258.","journal-title":"EMBO J"},{"key":"BFcddis2017263_CR44","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/emboj.2008.55","volume":"27","author":"P Penela","year":"2008","unstructured":"Penela P, Ribas C, Aymerich I, Eijkelkamp N, Barreiro O, Heijnen CJ et al. G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J 2008; 27: 1206\u20131218.","journal-title":"EMBO J"},{"key":"BFcddis2017263_CR45","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/sj.emboj.7601351","volume":"25","author":"A Salcedo","year":"2006","unstructured":"Salcedo A, Mayor F Jr, Penela P . Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J 2006; 25: 4752\u20134762.","journal-title":"EMBO J"},{"key":"BFcddis2017263_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tips.2007.02.008","volume":"28","author":"SS Ferguson","year":"2007","unstructured":"Ferguson SS . Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol Sci 2007; 28: 173\u2013179.","journal-title":"Trends Pharmacol Sci"},{"key":"BFcddis2017263_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbamem.2006.09.019","volume":"1768","author":"C Ribas","year":"2007","unstructured":"Ribas C, Penela P, Murga C, Salcedo A, Garcia-Hoz C, Jurado-Pueyo M et al. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 2007; 1768: 913\u2013922.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2017263_CR48","doi-asserted-by":"publisher","first-page":"18658","DOI":"10.1074\/jbc.M212103200","volume":"278","author":"KF Wan","year":"2003","unstructured":"Wan KF, Sambi BS, Tate R, Waters C, Pyne NJ . The inhibitory gamma subunit of the type 6 retinal cGMP phosphodiesterase functions to link c-Src and G-protein-coupled receptor kinase 2 in a signaling unit that regulates p42\/p44 mitogen-activated protein kinase by epidermal growth factor. J Biol Chem 2003; 278: 18658\u201318663.","journal-title":"J Biol Chem"},{"key":"BFcddis2017263_CR49","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"TL Yuan","year":"2008","unstructured":"Yuan TL, Cantley LC . PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27: 5497\u20135510.","journal-title":"Oncogene"},{"key":"BFcddis2017263_CR50","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/hep.25596","volume":"55","author":"W Wen","year":"2012","unstructured":"Wen W, Ding J, Sun W, Fu J, Chen Y, Wu K et al. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase\/Akt signaling facilitates liver cancer progression. Hepatology 2012; 55: 1787\u20131798.","journal-title":"Hepatology"},{"key":"BFcddis2017263_CR51","doi-asserted-by":"publisher","first-page":"e2103","DOI":"10.1038\/cddis.2016.23","volume":"7","author":"J Vier","year":"2016","unstructured":"Vier J, Groth M, Sochalska M, Kirschnek S . The anti-apoptotic Bcl-2 family protein A1\/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK\/STAT signaling. Cell Death Dis 2016; 7: e2103.","journal-title":"Cell Death Dis"},{"key":"BFcddis2017263_CR52","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1158\/1541-7786.MCR-13-0389","volume":"11","author":"F Zhang","year":"2013","unstructured":"Zhang F, Liu B, Wang Z, Yu XJ, Ni QX, Yang WT et al. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression. Mol Cancer Res 2013; 11: 1508\u20131520.","journal-title":"Mol Cancer Res"}],"updated-by":[{"DOI":"10.1038\/s41419-021-04465-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2017263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017263","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2017.263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:07:28Z","timestamp":1671732448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2017263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["BFcddis2017263"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.263","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]},"assertion":[{"value":"17 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-021-04465-2","URL":"https:\/\/doi.org\/10.1038\/s41419-021-04465-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}